Related Experiment Videos
Pharmacogenomic applications in clinical drug development.
1Bristol-Myers Squibb, Route 206 and Provinceline Road, Princeton, NJ 08540, USA. nicholas.dracopoli@bms.com
Cancer Chemotherapy and Pharmacology
|July 12, 2003
Summary
Pharmacogenomics aids oncology drug development by identifying patient subgroups likely to respond to treatments. This approach improves cancer therapy efficacy through personalized medicine strategies.
Area of Science:
- Oncology
- Pharmacogenomics
- Genetics
Background:
- Novel oncology drug development faces challenges due to low efficacy and tumor heterogeneity.
- Pharmacogenomics offers a promising avenue to enhance cancer therapy effectiveness.
Purpose of the Study:
- To explore the application of pharmacogenomics in developing novel oncology drugs.
- To highlight pharmacogenomics' role in improving patient stratification and treatment response.
Main Methods:
- Utilizing single nucleotide polymorphism (SNP) genotyping for drug-metabolizing and transport genes to assess pharmacokinetic variations.
- Employing genome-wide transcription profiling to identify expression profiles linked to pharmacodynamic variables in tumors.
Main Results:
- Pharmacogenomic approaches enable the screening of pharmacokinetic differences in drug exposure.
- Genome-wide transcription profiling correlates gene expression with tumor molecular changes and drug response.
Conclusions:
- Pharmacogenomics is crucial for improving cancer drug efficacy by stratifying patients.
- Early identification of likely responders through pharmacogenomics enhances personalized oncology treatment approaches.